Company family · HQ DE
Stada: medicine shortages
As of 2 Nov 2026, 349 Stada products have a reported shortage across 10 countries, covering 140 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Quetiapine | 25 | 29 Jan 2025 | Not stated | 12/16 | |
| Tacrolimus | 13 | 15 Feb 2025 | Increased demand | 6/16 | |
| Adalimumab | 7 | 17 Jul 2025 | Increased demand | 8/16 | |
| Aprepitant | 7 | 1 Aug 2024 | Increased demand | 12/16 | |
| Buprenorphine | 7 | 28 Apr 2026 | Manufacturing problem | 7/16 | |
| Cytarabine | 7 | 27 Sep 2024 | Manufacturing problem | 8/16 | |
| Duloxetine | 7 | 11 Sep 2025 | Increased demand | 12/16 | |
| Galantamine | 7 | 30 Jan 2025 | Not stated | 7/16 | |
| Ropinirole | 7 | 28 Jun 2024 | Manufacturing problem | 8/16 | |
| Levetiracetam | 6 | 29 May 2026 | Manufacturing problem | 9/16 | |
| Pamidronic Acid | 6 | 11 Dec 2025 | Manufacturing problem | 3/16 | |
| Repaglinide | 6 | 6 Apr 2026 | Not stated | 5/16 | |
| Salmeterol and Fluticasone | 6 | 2 Jun 2026 | Manufacturing problem | 6/16 | |
| Tolterodine | 6 | 11 Feb 2025 | Not stated | 8/16 | |
| Diclofenac | 5 | 1 Aug 2026 | Increased demand | 10/16 | |
| Sumatriptan | 5 | 3 Jul 2026 | Manufacturing problem | 13/16 | |
| Amisulpride | 4 | 1 Jul 2026 | Manufacturing problem | 5/16 | |
| Golimumab | 4 | 1 Mar 2026 | Manufacturing problem | 5/16 | |
| Ifosfamide | 4 | 3 Aug 2026 | Manufacturing problem | 12/16 | |
| Itraconazole | 4 | 11 Sep 2025 | Manufacturing problem | 11/16 | |
| Nifedipine | 4 | 15 Apr 2025 | Increased demand | 6/16 | |
| Travoprost | 4 | 7 Apr 2026 | Manufacturing problem | 7/16 | |
| Vardenafil | 4 | 20 Jun 2026 | Not stated | 6/16 | |
| Vinblastine | 4 | 3 Jul 2026 | Manufacturing problem | 5/16 | |
| Amoxicillin | 3 | 1 May 2024 | Increased demand | 7/16 | |
| Cefixime | 3 | 1 Oct 2018 | Increased demand | 5/16 | |
| Diltiazem | 3 | 17 Nov 2025 | Other | 7/16 | |
| Domperidone | 3 | 17 Nov 2025 | Manufacturing problem | 5/16 | |
| Etoricoxib | 3 | 18 Aug 2026 | Regulatory or licensing | 7/16 | |
| Fentanyl | 3 | 31 Jul 2026 | Increased demand | 9/16 | |
| Flutamide | 3 | 1 Mar 2022 | Increased demand | 2/16 | |
| Isosorbide Mononitrate | 3 | 8 Apr 2024 | Manufacturing problem | 5/16 | |
| Olmesartan Medoxomil and Amlodipine | 3 | 4 Sep 2026 | Manufacturing problem | 4/16 | |
| Risperidone | 3 | 19 Feb 2024 | Increased demand | 13/16 | |
| Rosuvastatin and Ezetimibe | 3 | 16 Nov 2026 | Increased demand | 6/16 | |
| Tamsulosin and Solifenacin | 3 | 14 Jun 2026 | Manufacturing problem | 5/16 | |
| Aceclofenac | 2 | 2 Aug 2026 | Increased demand | 3/16 | |
| Allopurinol | 2 | 1 May 2026 | Active ingredient shortage | 9/16 | |
| Ammonium Chloride | 2 | 1 Oct 2026 | Increased demand | 1/16 | |
| Anastrozole | 2 | 5 May 2026 | Increased demand | 5/16 | |
| Atomoxetine | 2 | 15 Jun 2026 | Not stated | 11/16 | |
| Betahistine | 2 | 10 Mar 2026 | Other | 5/16 | |
| Betamethasone | 2 | 28 Feb 2025 | Manufacturing problem | 7/16 | |
| Brinzolamide | 2 | 1 Aug 2026 | Manufacturing problem | 3/16 | |
| Brinzolamide, Combinations | 2 | 31 Dec 2025 | Not stated | 1/16 | |
| Calcitriol | 2 | 31 May 2024 | Manufacturing problem | 6/16 | |
| Calcium Folinate | 2 | 31 Jan 2025 | Not stated | 7/16 | |
| Dasatinib | 2 | 1 Dec 2026 | Not stated | 6/16 | |
| Deflazacort | 2 | 30 Jun 2026 | Increased demand | 1/16 | |
| Dimethyl Fumarate | 2 | 19 Aug 2026 | Not stated | 5/16 | |
| Doxorubicin | 2 | 16 Aug 2024 | Manufacturing problem | 8/16 | |
| Eltrombopag | 2 | 5 Aug 2026 | Increased demand | 4/16 | |
| Enalapril and Diuretics | 2 | 15 Sep 2026 | Regulatory or licensing | 1/16 | |
| Enalapril and lercanidipine | 2 | 22 Jun 2026 | Increased demand | 2/16 | |
| Escitalopram | 2 | 1 Jun 2026 | Regulatory or licensing | 10/16 | |
| Esomeprazole | 2 | 31 Oct 2026 | Manufacturing problem | 9/16 | |
| Fluoxetine | 2 | 4 Nov 2026 | Manufacturing problem | 8/16 | |
| Folic Acid | 2 | 25 Jul 2024 | Quality problem or recall | 3/16 | |
| Furosemide | 2 | 15 May 2025 | Manufacturing problem | 11/16 | |
| Ivabradine | 2 | 29 Oct 2026 | Manufacturing problem | 9/16 | |
| Lansoprazole | 2 | 7 Sep 2025 | Not stated | 8/16 | |
| Meropenem | 2 | 3 Nov 2026 | Not stated | 6/16 | |
| Methyldopa (Levorotatory) | 2 | 2 Dec 2024 | Manufacturing problem | 1/16 | |
| Mirtazapine | 2 | 23 Mar 2026 | Manufacturing problem | 10/16 | |
| Nimodipine | 2 | 29 Oct 2026 | Not stated | 1/16 | |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | 2 | 25 Jul 2026 | Not stated | 3/16 | |
| Ondansetron | 2 | 22 Jul 2026 | Manufacturing problem | 9/16 | |
| Oxazepam | 2 | 31 Oct 2024 | Increased demand | 2/16 | |
| Paracetamol | 2 | 23 Mar 2026 | Manufacturing problem | 10/16 | |
| Perindopril and Amlodipine | 2 | 3 Jul 2025 | Regulatory or licensing | 5/16 | |
| Perindopril and Diuretics | 2 | 5 Jul 2026 | Not stated | 6/16 | |
| Phenoxymethylpenicillin | 2 | 22 Sep 2026 | Manufacturing problem | 5/16 | |
| Risedronic Acid | 2 | 31 Dec 2026 | Manufacturing problem | 3/16 | |
| Sulfamethoxazole and Trimethoprim | 2 | 3 Jun 2026 | Manufacturing problem | 5/16 | |
| Temozolomide | 2 | 30 Jun 2026 | Manufacturing problem | 6/16 | |
| Teriparatide | 2 | 23 Apr 2026 | Increased demand | 5/16 | |
| Timolol, Combinations | 2 | 15 Jun 2026 | Not stated | 9/16 | |
| Urapidil | 2 | 1 Sep 2026 | Increased demand | 4/16 | |
| Venlafaxine | 2 | 2 Sep 2026 | Manufacturing problem | 10/16 | |
| Vincristine | 2 | 1 Jul 2026 | Not stated | 3/16 | |
| Vindesine | 2 | 1 Mar 2023 | Manufacturing problem | 3/16 | |
| Aciclovir | 1 | 13 May 2026 | Quality problem or recall | 6/16 | |
| Aciclovir | 1 | 1 Aug 2026 | Manufacturing problem | 3/16 | |
| Ambroxol | 1 | 30 Apr 2025 | Manufacturing problem | 3/16 | |
| Amiodarone | 1 | 31 May 2026 | Increased demand | 5/16 | |
| Amitriptyline | 1 | 25 Feb 2026 | Quality problem or recall | 5/16 | |
| Anagrelide | 1 | 25 Oct 2026 | Not stated | 3/16 | |
| Apomorphine | 1 | 2 Jan 2026 | Not stated | 2/16 | |
| Aripiprazole | 1 | 30 Apr 2026 | Other | 9/16 | |
| Bicalutamide | 1 | 1 Oct 2025 | Increased demand | 6/16 | |
| Chlorpromazine | 1 | 21 Sep 2026 | Manufacturing problem | 3/16 | |
| Clarithromycin | 1 | 9 Nov 2026 | Increased demand | 5/16 | |
| Clotrimazole | 1 | 9 Jun 2026 | Manufacturing problem | 3/16 | |
| Cromoglicic Acid | 1 | 22 Sep 2026 | Not stated | 1/16 | |
| Ebastine | 1 | 9 Mar 2026 | Not stated | 4/16 | |
| Eletriptan | 1 | 17 Aug 2026 | Manufacturing problem | 7/16 | |
| Erlotinib | 1 | 21 Aug 2026 | Not stated | 5/16 | |
| Famotidine | 1 | 8 Sep 2026 | Increased demand | 4/16 | |
| Felodipine | 1 | 8 Jan 2026 | Not stated | 5/16 | |
| Fesoterodine | 1 | 9 Nov 2026 | Increased demand | 2/16 | |
| Finasteride | 1 | 3 Aug 2026 | Manufacturing problem | 8/16 | |
| Fingolimod | 1 | 19 Dec 2025 | Manufacturing problem | 9/16 | |
| Flecainide | 1 | 28 Oct 2026 | Increased demand | 5/16 | |
| Formoterol and Beclometasone | 1 | 30 Apr 2026 | Increased demand | 1/16 | |
| Fosfomycin | 1 | 15 Jun 2026 | Not stated | 4/16 | |
| Gliclazide | 1 | 1 Jan 2026 | Manufacturing problem | 8/16 | |
| Indometacin | 1 | 10 Aug 2026 | Manufacturing problem | 1/16 | |
| Lacosamide | 1 | 19 Jun 2026 | Not stated | 6/16 | |
| Lamotrigine | 1 | 1 Jul 2026 | Increased demand | 9/16 | |
| Losartan and Diuretics | 1 | 21 Oct 2026 | Manufacturing problem | 4/16 | |
| Memantine | 1 | 2 Nov 2026 | Manufacturing problem | 8/16 | |
| Metamizole Sodium | 1 | 30 Oct 2026 | Manufacturing problem | 2/16 | |
| Metformin | 1 | 20 Aug 2024 | Manufacturing problem | 8/16 | |
| Metformin and Vildagliptin | 1 | 3 Nov 2026 | Manufacturing problem | 3/16 | |
| Metoprolol | 1 | 30 May 2026 | Manufacturing problem | 9/16 | |
| Mometasone | 1 | 31 Oct 2026 | Manufacturing problem | 5/16 | |
| Moxonidine | 1 | 3 Nov 2026 | Not stated | 2/16 | |
| Olanzapine | 1 | 5 Jun 2026 | Manufacturing problem | 13/16 | |
| Oxycodone and Naloxone | 1 | 1 Jan 2027 | Not stated | 2/16 | |
| Paroxetine | 1 | 6 Apr 2026 | Manufacturing problem | 8/16 | |
| Pazopanib | 1 | 29 Jul 2026 | Manufacturing problem | 4/16 | |
| Pirfenidone | 1 | 27 Oct 2026 | Manufacturing problem | 6/16 | |
| Posaconazole | 1 | 2 Nov 2026 | Not stated | 6/16 | |
| Pramipexole | 1 | 7 Sep 2026 | Increased demand | 6/16 | |
| Prednisolone | 1 | 18 Jul 2025 | Manufacturing problem | 2/16 | |
| Pregabalin | 1 | 1 Jul 2026 | Other | 11/16 | |
| Propranolol | 1 | 25 Feb 2026 | Increased demand | 7/16 | |
| Ramipril | 1 | 11 Nov 2026 | Not stated | 10/16 | |
| Ranibizumab | 1 | 14 Jul 2025 | Not stated | 2/16 | |
| Rivastigmine | 1 | 28 Apr 2026 | Not stated | 6/16 | |
| Sevelamer | 1 | 1 Sep 2026 | Increased demand | 5/16 | |
| Sorafenib | 1 | 28 Sep 2026 | Increased demand | 6/16 | |
| Tadalafil | 1 | 1 Jun 2026 | Not stated | 10/16 | |
| Terbinafine | 1 | 31 Aug 2026 | Increased demand | 5/16 | |
| Terbinafine | 1 | 1 Aug 2026 | Manufacturing problem | 3/16 | |
| Thiocolchicoside | 1 | 31 Jul 2025 | Manufacturing problem | 1/16 | |
| Tramadol | 1 | 10 Jul 2026 | Manufacturing problem | 7/16 | |
| Valaciclovir | 1 | 31 Dec 2026 | Increased demand | 10/16 | |
| Xylometazoline | 1 | 1 Apr 2026 | Manufacturing problem | 1/16 | |
| Zoledronic Acid | 1 | 11 Sep 2026 | Increased demand | 7/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.